CP-023 Use of intravitreal antiangiogenic drug in a large study in the treatment of retinopathy of prematurity

BackgroundRetinopathy of prematurity (ROP) is a proliferative disease of the retinal vasculature that can cause severe visual loss in premature newborns. Intravitreal bevacizumab has shown promise as a treatment for ROP.PurposeTo evaluate the efficacy and safety of intravitreal bevacizumab in preter...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A10-A10
Hauptverfasser:	Fernández-Ginés, FD, Rodríguez-Cuadros, TB, Paz, S Cañizares, Molina-Cuadrado, E
Format:	Artikel
Sprache:	eng
Schlagworte:	Gestational age Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!